http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101725600-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6813 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6844 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate | 2014-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2017-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2017-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101725600-B1 |
titleOfInvention | Methods for providing information for antipsychotic agent therapeutic reaction using genetic polymorphism |
abstract | The present invention provides a method for providing information for predicting a therapeutic response to a dopamine receptor antagonist class antipsychotic drug, which comprises amplifying a single base polymorphism rs1079597 and rs1800497 regions of DNA in a sample separated from an individual or hybridizing with a probe, single dopamine D 2 receptor (DRD2) polymorphism rs1079597 and dopamine receptor antagonist-based anti-psychotic therapeutic effect on drug predicted composition and dopamine D 2 receptor (DRD2) containing formulation capable of amplifying or hybridizing rs1800497 site of The present invention relates to a kit for predicting the therapeutic effect of a dopamine receptor antagonist family of antipsychotic drugs comprising an agent capable of amplifying or detecting the base polymorphisms rs1079597 and rs1800497. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200059937-A |
priorityDate | 2014-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 73.